Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.

Karpova D, Rettig MP, Ritchey J, Cancilla D, Christ S, Gehrs L, Chendamarai E, Evbuomwan MO, Holt M, Zhang J, Abou-Ezzi G, Celik H, Wiercinska E, Yang W, Gao F, Eissenberg LG, Heier RF, Arnett SD, Meyers MJ, Prinsen MJ, Griggs DW, Trumpp A, Ruminski PG, Morrow DM, Bonig HB, Link DC, DiPersio JF.

J Clin Invest. 2019 May 14;129(7):2745-2759. doi: 10.1172/JCI124738.

2.

An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies.

Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, Gehrs LN, Prior JL, Achilefu S, Miller CA, Fronick CC, O'Neal J, Gao F, Weinstock DM, Gutierrez A, Fulton RS, DiPersio JF.

Leukemia. 2018 Sep;32(9):1970-1983. doi: 10.1038/s41375-018-0065-5. Epub 2018 Feb 20.

3.

Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.

Ghobadi A, Choi J, Fiala MA, Fletcher T, Liu J, Eissenberg LG, Abboud C, Cashen A, Vij R, Schroeder MA, Pusic I, Stockerl-Goldstein K, Jacoby M, Uy G, DiPersio J, Westervelt P.

Leuk Res. 2016 Oct;49:1-6. doi: 10.1016/j.leukres.2016.07.010. Epub 2016 Jul 22.

4.

Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform.

Al-Hussaini M, Rettig MP, Ritchey JK, Karpova D, Uy GL, Eissenberg LG, Gao F, Eades WC, Bonvini E, Chichili GR, Moore PA, Johnson S, Collins L, DiPersio JF.

Blood. 2016 Jan 7;127(1):122-31. doi: 10.1182/blood-2014-05-575704. Epub 2015 Nov 3.

5.

[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility.

Eissenberg LG, Rettig MP, Ritchey JK, Prior JL, Schwarz SW, Frye J, White BS, Fulton RS, Ghobadi A, Cooper ML, Couriel DR, Seegulam ME, Piwnica-Worms D, Dehdashti F, Cornetta K, DiPersio JF.

Mol Ther. 2015 Jun;23(6):1110-1122. doi: 10.1038/mt.2015.48. Epub 2015 Mar 25.

6.

Suicide genes: monitoring cells in patients with a safety switch.

Eissenberg LG, Rettig M, Dehdashti F, Piwnica-Worms D, DiPersio JF.

Front Pharmacol. 2014 Nov 6;5:241. doi: 10.3389/fphar.2014.00241. eCollection 2014.

7.

Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor.

Rappleye CA, Eissenberg LG, Goldman WE.

Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1366-70. Epub 2007 Jan 16.

8.

Alterations to the cell wall of Histoplasma capsulatum yeasts during infection of macrophages or epithelial cells.

Eissenberg LG, Moser SA, Goldman WE.

J Infect Dis. 1997 Jun;175(6):1538-44.

PMID:
9180203
9.

Phenotypic variation and persistence of Histoplasma capsulatum yeasts in host cells.

Eissenberg LG, Poirier S, Goldman WE.

Infect Immun. 1996 Dec;64(12):5310-4.

10.

Histoplasma capsulatum modulates the acidification of phagolysosomes.

Eissenberg LG, Goldman WE, Schlesinger PH.

J Exp Med. 1993 Jun 1;177(6):1605-11.

11.

Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis.

Eissenberg LG, Goldman WE.

Clin Microbiol Rev. 1991 Oct;4(4):411-21. Review.

13.

Phagosome-lysosome fusion in P388D1 macrophages infected with Histoplasma capsulatum.

Eissenberg LG, Schlesinger PH, Goldman WE.

J Leukoc Biol. 1988 Jun;43(6):483-91.

PMID:
2454277
14.

Fusion of lysosomes with phagosomes containing Histoplasma capsulatum: use of fluoresceinated dextran.

Eissenberg LG, Goldman WE.

Adv Exp Med Biol. 1988;239:53-61. Review. No abstract available.

PMID:
2462337
15.

Histoplasma capsulatum fails to trigger release of superoxide from macrophages.

Eissenberg LG, Goldman WE.

Infect Immun. 1987 Jan;55(1):29-34.

16.

Chlamydia psittaci elementary body envelopes: ingestion and inhibition of phagolysosome fusion.

Eissenberg LG, Wyrick PB, Davis CH, Rumpp JW.

Infect Immun. 1983 May;40(2):741-51.

17.

Supplemental Content

Loading ...
Support Center